相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Jens Y. Humrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients
Gal Yaniv et al.
AUTOIMMUNITY REVIEWS (2015)
Regulatory plasma cells
Simon Fillatreau
CURRENT OPINION IN PHARMACOLOGY (2015)
Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang
Simon Fillatreau
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis
Susan A. Olalekan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
Jimmy Z. Liu et al.
NATURE GENETICS (2015)
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein et al.
JAMA NEUROLOGY (2015)
Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
Venkat Reddy et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis
L. Yeo et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response
Diana G. Adlowitz et al.
PLOS ONE (2015)
Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
Carolyn J. Owen et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
Resident Bacteria-Stimulated Interleukin-10-Secreting B Cells Ameliorate T-Cell-Mediated Colitis by Inducing T-Regulatory-1 Cells That Require Interleukin-27 Signaling
Yoshiyuki Mishima et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
B- type suppression: A role played by regulatory B cells or regulatory plasma cells?
Stefanie Ries et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
Masanori Matsumoto et al.
IMMUNITY (2014)
Role of Regulatory B Cells in Chronic Intestinal Inflammation: Association with Pathogenesis of Crohn's Disease
Akihiko Oka et al.
INFLAMMATORY BOWEL DISEASES (2014)
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
G. Cambridge et al.
JOURNAL OF AUTOIMMUNITY (2014)
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Arumugam Palanichamy et al.
JOURNAL OF IMMUNOLOGY (2014)
Plasma Cells in the Mucosa of Patients with Inflammatory Bowel Disease Produce Granzyme B and Possess Cytotoxic Activities
Maria Laura Cupi et al.
JOURNAL OF IMMUNOLOGY (2014)
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen et al.
NATURE (2014)
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
Ren-Xi Wang et al.
NATURE MEDICINE (2014)
Emerging cell and cytokine targets in rheumatoid arthritis
Gerd R. Burmester et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis
Hannah Beckwith et al.
NEPHRON CLINICAL PRACTICE (2014)
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
Yusei Miyazaki et al.
PLOS ONE (2014)
Regulatory B Cells Are Inversely Associated with Disease Activity in Rheumatoid Arthritis
Jinhyun Kim et al.
YONSEI MEDICAL JOURNAL (2014)
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation
Julia Sieber et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Murine Gammaherpesvirus M2 Protein Induction of IRF4 via the NFAT Pathway Leads to IL-10 Expression in B Cells
Udaya S. Rangaswamy et al.
PLOS PATHOGENS (2014)
B Cell-Specific Expression of Inducible Costimulator Ligand Is Necessary for the Induction of Arthritis in Mice
Keith M. Hamel et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Could Osteoprotegerin and TNF-Related Apoptosis-Inducing Ligand Assessments Help Us to Manage Early Rheumatoid Arthritis? Results from the Espoir Cohort
Rachel Audo et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Naturally secreted immunoglobulins limit B1 and MZ B-cell numbers through a microbiota-independent mechanism
Andreia C. Lino et al.
BLOOD (2013)
Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
Hui Peng et al.
CLINICAL RHEUMATOLOGY (2013)
Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation
Michihide Uo et al.
GUT (2013)
B Cells Secrete Eotaxin-1 in Human Inflammatory Bowel Disease
Mian Qasim Rehman et al.
INFLAMMATORY BOWEL DISEASES (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
Nicolas Molnarfi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source
Melanie D. Leech et al.
JOURNAL OF IMMUNOLOGY (2013)
Peritoneal Cavity Regulatory B Cells (B10 Cells) Modulate IFN-γ+CD4+ T Cell Numbers during Colitis Development in Mice
Damian Maseda et al.
JOURNAL OF IMMUNOLOGY (2013)
Autoimmune Rheumatic Diseases 3 Immunopathogenic mechanisms of systemic autoimmune disease
Marie Wahren-Herlenius et al.
LANCET (2013)
Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
B. Duxbury et al.
LUPUS (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
Fabian Flores-Borja et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
IL-10-Producing Regulatory B10 Cells Ameliorate Collagen-Induced Arthritis via Suppressing Th17 Cell Generation
Min Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis
Maria J. H. Boumans et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
B Cell-Derived IL-10 Does Not Regulate Spontaneous Systemic Autoimmunity in MRL.Faslpr Mice
Lino L. Teichmann et al.
JOURNAL OF IMMUNOLOGY (2012)
Multiple Courses of Rituximab Produce Sustained Clinical and Radiographic Efficacy and Safety in Patients with Rheumatoid Arthritis and an Inadequate Response to 1 or More Tumor Necrosis Factor Inhibitors: 5-Year Data from the REFLEX Study
Edward C. Keystone et al.
JOURNAL OF RHEUMATOLOGY (2012)
Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis
Natalie A. Carter et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
Lorraine Yeo et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment
Preeti Lal et al.
ARTHRITIS AND RHEUMATISM (2011)
Atacicept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate Results of a Phase II, Randomized, Placebo-Controlled Trial
R. F. van Vollenhoven et al.
ARTHRITIS AND RHEUMATISM (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts
Charles N. Bernstein et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
Keith Leiper et al.
GUT (2011)
Genetics of rheumatoid arthritis: what have we learned?
Marieke Bax et al.
IMMUNOGENETICS (2011)
Mice Lacking Endogenous IL-10-Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells
Natalie A. Carter et al.
JOURNAL OF IMMUNOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells
Erika Cretney et al.
NATURE IMMUNOLOGY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice
Patrizia Scapini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab
Henrik E. Mei et al.
BLOOD (2010)
Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection
Patricia Neves et al.
IMMUNITY (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
CXCL12 Is a Constitutive and Inflammatory Chemokine in the Intestinal Immune System
Iris Dotan et al.
INFLAMMATORY BOWEL DISEASES (2010)
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
Dermot P. B. McGovern et al.
NATURE GENETICS (2010)
Severe Ulcerative Colitis After Rituximab Therapy
Daniela S. Ardelean et al.
PEDIATRICS (2010)
Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
Thomas Doerner et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Atacicept: targeting B cells in multiple sclerosis
Hans-Peter Hartung et al.
Therapeutic Advances in Neurological Disorders (2010)
Delayed Acquisition of Somatic Hypermutations in Repopulated IgD+CD27+Memory B Cell Receptors After Rituximab Treatment
Khalid Muhammad et al.
ARTHRITIS AND RHEUMATISM (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
An FcRn-Dependent Role for Anti-flagellin Immunoglobulin G in Pathogenesis of Colitis in Mice
Kanna Kobayashi et al.
GASTROENTEROLOGY (2009)
Absence of the Transcriptional Repressor Blimp-1 in Hematopoietic Lineages Reveals Its Role in Dendritic Cell Homeostatic Development and Function
Yueh-Hsuan Chan et al.
JOURNAL OF IMMUNOLOGY (2009)
Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
Paul A. Blair et al.
JOURNAL OF IMMUNOLOGY (2009)
Hyperactivated B cells in human inflammatory bowel disease
Ansu Mammen Noronha et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
Barry Bresnihan et al.
JOURNAL OF RHEUMATOLOGY (2009)
REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis
Peter K. Gregersen et al.
NATURE GENETICS (2009)
Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation
Michael McPherson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Helminth infections associated with multiple sclerosis induce regulatory B cells
Jorge Correale et al.
ANNALS OF NEUROLOGY (2008)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
Anti-CD20 therapy in patients with rheumatoid arthritis -: Predictors of response and B cell subset regeneration after repeated treatment
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2008)
Highly Sensitive B Cell Analysis Predicts Response to Rituximab Therapy in Rheumatoid Arthritis
Shouvik Dass et al.
ARTHRITIS AND RHEUMATISM (2008)
Integration of B cells and CD8(+) T in the protective regulation of systemic epithelial inflammation
Bo Wei et al.
CLINICAL IMMUNOLOGY (2008)
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease
D. E. Fassi et al.
GUT (2008)
Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease
John N. Gordon et al.
INFLAMMATORY BOWEL DISEASES (2008)
Suppression of proteoglycan-induced arthritis by anti-CD20 B cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity
Keith Hamel et al.
JOURNAL OF IMMUNOLOGY (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Atacicept in patients with rheumatoid arthritis
P. P. Tak et al.
ARTHRITIS AND RHEUMATISM (2008)
IBD serological panels: Facts and perspectives
Lourent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2007)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells
Wanda Niedbala et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Exacerbation of ulcerative colitis after rituximab salvage therapy
Martin Goetz et al.
INFLAMMATORY BOWEL DISEASES (2007)
Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis
Shannon K. O'Neill et al.
JOURNAL OF IMMUNOLOGY (2007)
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
Marc Ferrante et al.
GUT (2007)
B cell depletion delays collagen-induced arthritis in mice: Arthritis induction requires synergy between humoral and cell-mediated immunity
Koichi Yanaba et al.
JOURNAL OF IMMUNOLOGY (2007)
Novel suppressive function of transitional 2 B cells in experimental arthritis
Jamie G. Evans et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
John D. Rioux et al.
NATURE GENETICS (2007)
Association between parasite infection and immune responses in multiple sclerosis
Jorge Correale et al.
ANNALS OF NEUROLOGY (2007)
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness
Hans Link et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2006)
Transcriptional repressor Blimp-1 regulates T cell homeostasis and function
GA Martins et al.
NATURE IMMUNOLOGY (2006)
Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance
A Kallies et al.
NATURE IMMUNOLOGY (2006)
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
P Emery et al.
ARTHRITIS AND RHEUMATISM (2006)
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis
KA Kuhn et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis
Y Jinno et al.
VIRCHOWS ARCHIV (2006)
Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor FcγRIIB
SB Petkova et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis
PH Lalive et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Macrophage migration inhibitory factor promotes intestinal tumorigenesis
JM Wilson et al.
GASTROENTEROLOGY (2005)
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response
T Sato et al.
GUT (2005)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis
SK O'Neill et al.
JOURNAL OF IMMUNOLOGY (2005)
Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets
B Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
KT Steeve et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Urocortin 1 in colonic mucosa in patients with ulcerative colitis
M Saruta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2003)
Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2b mice
C Bourquin et al.
JOURNAL OF IMMUNOLOGY (2003)
Rituximab therapy and autoimmune disorders - Prospects for anti-B cell therapy
GJ Silverman et al.
ARTHRITIS AND RHEUMATISM (2003)
Prevention of arthritis by interleukin 10-producing B cells
C Mauri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Development of inflammation in proteoglycan-induced arthritis is dependent on FcγR regulation of the cytokine/chemokine environment
CD Kaplan et al.
JOURNAL OF IMMUNOLOGY (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Blood dendritic cells interact with splenic marginal zone B cells to initiate T-Independent immune responses
M Balázs et al.
IMMUNITY (2002)
Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-γ
G Schwarz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
E Romas et al.
BONE (2002)
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
A Mizoguchi et al.
IMMUNITY (2002)
Development of chronic colitis is dependent on the cytokine MIF
YP de Jong et al.
NATURE IMMUNOLOGY (2001)
Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance
H Murakami et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
JCW Edwards et al.
RHEUMATOLOGY (2001)
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
A Bitton et al.
GASTROENTEROLOGY (2001)
Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process
C Mauri et al.
NATURE MEDICINE (2000)
Regulatory role of mature B cells in a murine model of inflammatory bowel disease
E Mizoguchi et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
